InDevR raises $7M in series A round with Adjuvant Capital investment

InDevR raises $7M in series A round with Adjuvant Capital investment

BOULDER -- InDevR, Inc. , a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced it has raised... Read More

Tuesday September 10, 2019 0 comments Tags: Boulder, InDevR, Adjuvant Capital, Glenn Rockman, Kathy Rowlen